Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2025 of 6351
-
SPINRAZA study tracks movement in adults with spinal muscular atrophy
Disease control OngoingSPINRAZA® (Nusinersen) is the first intrathecal administered drug which was approved by the FDA to treat SMA children and adults (2016). The aim is to monitor the evolution of the Motor Function Measure-32 for SMA type II adult patients treated with SPINRAZA® (Nusinersen).
Sponsor: Centre Hospitalier Universitaire de Nice • Aim: Disease control
Last updated Jun 27, 2026 08:00 UTC
-
New coordinated care approach aims to boost stroke recovery
Disease control CompletedStroke is the 5th leading cause of death and the leading cause of adult disability in the United States (US). Stroke is a complex disease with multiple interacting risk factors (including genetic, high blood pressure and cholesterol, and lifestyle factors like smoking, diet, and …
Sponsor: Vanderbilt University Medical Center • Aim: Disease control
Last updated Jun 27, 2026 12:32 UTC
-
Breath sniffing device may predict cancer drug success
Diagnosis CompletedImmunotherapy with agents stimulating the immune system to act against cancer are now a new standard of care in various cancers as lung cancer and melanoma, but also bladder cancer, kidney cancer and head \& neck cancer. However, even though a subset of patients derives long-term…
Sponsor: University Health Network, Toronto • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
New cocktail of drugs takes on multiple myeloma
Disease control OngoingThe purpose of this study is to identify recommended Phase 2 doses (RP2Ds) for each treatment combination (between daratumumab plus talquetamab and teclistamab plus daratumumab with or without pomalidomide) and to characterize the safety of each RP2D for selected treatment combin…
Phase 1 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Aug 30, 2026 00:00 UTC
-
Blood test may replace needle biopsy for thyroid cancer
Diagnosis Recruiting nowThis study is being done to help researchers learn more about and successfully diagnose cancer using blood samples and tissue samples from surgeries in patients with suspicious thyroid nodules or thyroid cancer. Diagnosing cancer in this way, as opposed to biopsies, may be less i…
Sponsor: Jonsson Comprehensive Cancer Center • Aim: Diagnosis
Last updated Jun 27, 2026 11:00 UTC
-
5-Day brain zapping trial aims to lift severe depression fast
Symptom relief OngoingIn this proposal the investigators will use an accelerated TMS protocol that concentrates the magnetic stimulation that would usually occur over 6 weeks into 10 treatment sessions per days, for 5 consecutive days in patient with treatment-refractory depression. This protocol will…
Sponsor: University of Pennsylvania • Aim: Symptom relief
Last updated Jun 27, 2026 08:11 UTC
-
Keto diet shows promise for painful leg fat disorder in women
Symptom relief CompletedLipedema is a chronic fat tissue disorder that usually affects the lower limbs, excluding the feet. Clinical symptoms of lipedema include a noticeable disproportion between the upper and lower body, a tendency to easy bruising, and pain in the fatty tissue. It is a common disorde…
Sponsor: Wroclaw Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 12:08 UTC
-
New combo therapy for endometrial cancer shows promise in early trial
Disease control OngoingThe purpose of this single arm, open label study is to evaluate the feasibility of pembrolizumab combined with radiation administered to the upper part of the vagina (vaginal cuff brachytherapy) followed by three cycles of pembrolizumab and chemotherapy in patients with endometri…
Phase 1 • Sponsor: University of Oklahoma • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Balloon battle: which device keeps leg arteries open longer?
Disease control OngoingThe BIOPACT RCT tiral investigates the efficacy and safety of stenosis, restenosis or occlusions in the femoropopliteal artery of patients presenting a rutherford classification 2,3 or 4 with a Passeo-18 Lux drug-coated balloon of Biotronik. The Paclitaxel eluting balloons are de…
Sponsor: KANDO Research • Aim: Disease control
Last updated Jun 27, 2026 13:06 UTC
-
New shorter radiation therapy could tame brain tumors
Disease control Recruiting nowThis phase II trial studies how well hypofractionated proton or photon radiation therapy works in treating patients with brain tumors. Hypofractionated radiation therapy delivers higher doses of radiation therapy over a shorter period of time and may kill more tumor cells. A shor…
Sponsor: Emory University • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
A pill that fights warts from the inside: trial puts immune-regulating capsule to the test
Disease control Recruiting nowHuman papillomavirus (HPV) infection is very common, as most people will experience infection during their lifetime. The most common manifestation of HPV infection is common warts. Common warts may appear at any age. Conventional treatments can be used to treat warts and they ar…
Phase 4 • Sponsor: Labo'Life • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New program aims to keep young adults on opioid recovery meds
Disease control Recruiting nowYouth are disproportionately affected by the current opioid crisis with catastrophic consequences, and young adults with opioid use disorder (OUD) often struggle with adherence to relapse prevention medications. The Youth Opioid Recovery Support (YORS) model is a promising, innov…
Sponsor: Potomac Health Foundations • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
New study aims to help smokers with HIV kick the habit for good
Disease control OngoingThe advent of anti-retroviral therapy (ART) for people living with HIV/AIDS (PLWHA) substantially improved life expectancy but has also led to the critical need to address modifiable risk factors associated with cancer and cardiovascular disease, such as tobacco smoking. HIV-infe…
Phase 3 • Sponsor: Abramson Cancer Center at Penn Medicine • Aim: Disease control
Last updated Sep 06, 2026 00:00 UTC
-
New study aims to spot heart defects in newborns with simple blood test
Diagnosis CompletedEstablish a cardiovascular biomarker profile to help screening for congenital heart disease in infants and children as well as use non-invasive cardiac imaging in combination with such profiling to better predict the need for future cardiac interventions such as open heart surger…
Sponsor: Lund University Hospital • Aim: Diagnosis
Last updated Jun 27, 2026 12:30 UTC
-
Could a daily dab of sirolimus ease tongue cysts?
Disease control CompletedLingual microcystic lymphatic malformations (LMLMs) are rare congenital vascular malformations, presenting as clusters of cysts filled with lymph fluid or blood. They are responsible for a heavy burden even with small well-limited lesions because of oozing, bleeding, infections, …
Phase 2 • Sponsor: University Hospital, Tours • Aim: Disease control
Last updated Jun 27, 2026 07:59 UTC
-
Experimental drug losmapimod tested for rare muscle disease
Disease control Stopped earlyThis study is an open-label extension to evaluate the safety and tolerability of long-term dosing of Losmapimod in patients with FSHD1 who participated in the ReDux4 study.
Phase 2 • Sponsor: Fulcrum Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:52 UTC
-
At-Home HPV test could help underserved women skip the clinic
Prevention CompletedRegularly attending for Pap test cervical cancer screening in a clinic is often unfeasible and/or unacceptable to many women. This study evaluates if mailing and testing self-sampled kits for high-risk human papillomavirus (HPV) can cost-effectively increase screening participati…
Sponsor: Baylor College of Medicine • Aim: Prevention
Last updated Jun 26, 2026 13:41 UTC
-
New hope for kids with pompe: enzyme combo trial underway
Disease control OngoingThis is a Phase 3, open-label, multicenter study to evaluate the safety, PK, efficacy, PD, and immunogenicity of Cipaglucosidase Alfa/Miglustat treatment in enzyme replacement therapy (ERT)-experienced and ERT-naïve pediatric subjects with Pompe disease, aged 0 to \< 18 years
Phase 3 • Sponsor: Amicus Therapeutics • Aim: Disease control
Last updated Jun 27, 2026 07:55 UTC
-
Experimental drug duo targets Hard-to-Treat cancers
Disease control OngoingThis phase I trial studies the best dose of sonidegib when given together with pembrolizumab and to see how well they work in treating patients with solid tumor that has spread to other places in the body (advanced). Sonidegib may stop the growth of tumor cells by blocking some o…
Phase 1 • Sponsor: Mayo Clinic • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC
-
Laser and Light-Sensitive drug shrink lung tumors in early trial
Symptom relief CompletedThis Phase I/Il studies the side effects of endobronchial ultrasound guided interstitial photodynamic therapy work in treating patients with lung cancer that has spread to nearby tissues or lymph nodes. Photodynamic therapy consists of injecting a light sensitive drug called a ph…
Phase 1/2 • Sponsor: Roswell Park Cancer Institute • Aim: Symptom relief
Last updated Jun 27, 2026 12:33 UTC